Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Nanobody-CD16 Catch Bond Reveals NK Cell Mechanosensitivity.

González C, Chames P, Kerfelec B, Baty D, Robert P, Limozin L.

Biophys J. 2019 Apr 23;116(8):1516-1526. doi: 10.1016/j.bpj.2019.03.012. Epub 2019 Mar 23.

PMID:
30979550
2.

Phage Display and Selections on Purified Antigens.

Colazet M, Chames P.

Methods Mol Biol. 2018;1827:165-178. doi: 10.1007/978-1-4939-8648-4_9.

PMID:
30196497
3.

Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.

Ramos-Gomes F, Bode J, Sukhanova A, Bozrova SV, Saccomano M, Mitkovski M, Krueger JE, Wege AK, Stuehmer W, Samokhvalov PS, Baty D, Chames P, Nabiev I, Alves F.

Sci Rep. 2018 Mar 15;8(1):4595. doi: 10.1038/s41598-018-22973-8.

4.

Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidation.

Scholler P, Nevoltris D, de Bundel D, Bossi S, Moreno-Delgado D, Rovira X, Møller TC, El Moustaine D, Mathieu M, Blanc E, McLean H, Dupuis E, Mathis G, Trinquet E, Daniel H, Valjent E, Baty D, Chames P, Rondard P, Pin JP.

Nat Commun. 2017 Dec 6;8(1):1967. doi: 10.1038/s41467-017-01489-1.

5.

In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.

Krüwel T, Nevoltris D, Bode J, Dullin C, Baty D, Chames P, Alves F.

Sci Rep. 2016 Feb 25;6:21834. doi: 10.1038/srep21834.

6.

V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.

Morgand M, Bouvin-Pley M, Plantier JC, Moreau A, Alessandri E, Simon F, Pace CS, Pancera M, Ho DD, Poignard P, Bjorkman PJ, Mouquet H, Nussenzweig MC, Kwong PD, Baty D, Chames P, Braibant M, Barin F.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):237-45. doi: 10.1097/QAI.0000000000000854.

7.

Anti-Mesothelin Nanobodies for Both Conventional and Nanoparticle-Based Biomedical Applications.

Prantner AM, Turini M, Kerfelec B, Joshi S, Baty D, Chames P, Scholler N.

J Biomed Nanotechnol. 2015 Jul;11(7):1201-12.

PMID:
26307843
8.

Detection of carcinoembryonic antigen using single-domain or full-size antibodies stained with quantum dot conjugates.

Rousserie G, Grinevich R, Brazhnik K, Even-Desrumeaux K, Reveil B, Tabary T, Chames P, Baty D, Cohen JH, Nabiev I, Sukhanova A.

Anal Biochem. 2015 Jun 1;478:26-32. doi: 10.1016/j.ab.2015.02.029. Epub 2015 Mar 9.

PMID:
25766579
9.

Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.

Nevoltris D, Lombard B, Dupuis E, Mathis G, Chames P, Baty D.

ACS Nano. 2015 Feb 24;9(2):1388-99. doi: 10.1021/nn505752u. Epub 2015 Jan 26.

PMID:
25603171
10.

Selection of intracellular single-domain antibodies targeting the HIV-1 Vpr protein by cytoplasmic yeast two-hybrid system.

Matz J, Hérate C, Bouchet J, Dusetti N, Gayet O, Baty D, Benichou S, Chames P.

PLoS One. 2014 Dec 1;9(12):e113729. doi: 10.1371/journal.pone.0113729. eCollection 2014.

11.

A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy.

Turini M, Chames P, Bruhns P, Baty D, Kerfelec B.

Oncotarget. 2014 Jul 30;5(14):5304-19.

12.

Multiphoton imaging of tumor biomarkers with conjugates of single-domain antibodies and quantum dots.

Hafian H, Sukhanova A, Turini M, Chames P, Baty D, Pluot M, Cohen JH, Nabiev I, Millot JM.

Nanomedicine. 2014 Nov;10(8):1701-9. doi: 10.1016/j.nano.2014.05.014. Epub 2014 Jun 15.

PMID:
24941465
13.

Highly sensitive single domain antibody-quantum dot conjugates for detection of HER2 biomarker in lung and breast cancer cells.

Rakovich TY, Mahfoud OK, Mohamed BM, Prina-Mello A, Crosbie-Staunton K, Van Den Broeck T, De Kimpe L, Sukhanova A, Baty D, Rakovich A, Maier SA, Alves F, Nauwelaers F, Nabiev I, Chames P, Volkov Y.

ACS Nano. 2014 Jun 24;8(6):5682-95. doi: 10.1021/nn500212h. Epub 2014 Jun 11.

PMID:
24873349
14.

Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display.

Even-Desrumeaux K, Nevoltris D, Lavaut MN, Alim K, Borg JP, Audebert S, Kerfelec B, Baty D, Chames P.

Mol Cell Proteomics. 2014 Feb;13(2):653-65. doi: 10.1074/mcp.O112.025486. Epub 2013 Dec 20.

15.

Heavy chain-only IgG2b llama antibody effects near-pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites.

Acharya P, Luongo TS, Georgiev IS, Matz J, Schmidt SD, Louder MK, Kessler P, Yang Y, McKee K, O'Dell S, Chen L, Baty D, Chames P, Martin L, Mascola JR, Kwong PD.

J Virol. 2013 Sep;87(18):10173-81. doi: 10.1128/JVI.01332-13. Epub 2013 Jul 10. Erratum in: J Virol. 2015 Jan;89(1):883-5.

16.

Single-domain antibody-based and linker-free bispecific antibodies targeting FcγRIII induce potent antitumor activity without recruiting regulatory T cells.

Rozan C, Cornillon A, Pétiard C, Chartier M, Behar G, Boix C, Kerfelec B, Robert B, Pèlegrin A, Chames P, Teillaud JL, Baty D.

Mol Cancer Ther. 2013 Aug;12(8):1481-91. doi: 10.1158/1535-7163.MCT-12-1012. Epub 2013 Jun 11.

17.

Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and coreceptor binding sites of HIV-1 gp120.

Matz J, Kessler P, Bouchet J, Combes O, Ramos OH, Barin F, Baty D, Martin L, Benichou S, Chames P.

J Virol. 2013 Jan;87(2):1137-49. doi: 10.1128/JVI.00461-12. Epub 2012 Nov 14.

18.

Affinity determination of biotinylated antibodies by flow cytometry.

Even-Desrumeaux K, Chames P.

Methods Mol Biol. 2012;907:443-9. doi: 10.1007/978-1-61779-974-7_25.

PMID:
22907367
19.

Phage display and selections on cells.

Even-Desrumeaux K, Chames P.

Methods Mol Biol. 2012;907:225-35. doi: 10.1007/978-1-61779-974-7_12.

PMID:
22907354
20.

Phage display and selections on purified antigens.

Matz J, Chames P.

Methods Mol Biol. 2012;907:213-24. doi: 10.1007/978-1-61779-974-7_11.

PMID:
22907353

Supplemental Content

Loading ...
Support Center